Prospective study of pancreatic exocrine function after pancreaticoduodenectomy

Prospective study of pancreatic exocrine function after pancreaticoduodenectomy - Prospective study of pancreatic exocrine function after pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005758

Enrollment

Registered

2011-06-15

Start date

2011-06-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periampullary tumor

Interventions

Duct-to-mucosa pancreatico-gastrostomy for pancreatico-enterostomy Duct-to-mucosa pancreatico-jejunosotmy for pancreatico-enterostomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: On the diagnosis of periampullary malignancy, benign tumor or inflammatory disease, the patient is going to undergo pancreaticoduodenectomy with duodeno-jejunostomy

Exclusion criteria

Exclusion criteria: 1.Patients with acute ischemic heart disease 2.Patients with liver cirrhosis or active hepatitis 3. Patients with interstitial pneumonia or fibroid lung who require oxygen administration 4. Patients with chronic renal failure requiring dialysis 5. Patients with other malignant disease 6. Patients who require concomitant resection of other organ 7. Patients who are diagnosed to be ineligible by the investigator.

Design outcomes

Primary

Measure	Time frame
The Incidence of pancreatic exocrine inefficiency one year after surgery	—

Secondary

Measure	Time frame
The Incidence of pancreatic exocrine inefficiency three months and two year after surgery	—

Countries

Japan

Contacts

Public ContactKenichiro Uemura

Hiroshima University Hospital Gastrointestinal Surgery

082-257-5216

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026